The MicroPulse P3 device has become an essential part of my armamentarium for use in glaucoma surgical procedures. It provides a very safe and efficacious solution for IOP control. I have used MicroPulse P3 for some of my most complicated cases but also I feel comfortable enough using it for patients with earlier disease in which we want to avoid a filtering bleb or the placement of hardware in the eye.
Robert Noecker, MD, MBA
The MicroPulse P3 device has given me over 30% IOP lowering. With patients that are non-compliant with their medication, or we are really trying to keep off their medication, the MicroPulse P3 device allows me to treat patients more aggressively
Steven Vold, MD
Glaucoma Therapy Device Options
Glaucoma Therapy Device Options The patented MicroPulse® P3 and G-Probe™ devices are used to deliver laser energy for the treatment of glaucoma.
Efficacy – Confidence in IOP Control Long-term results from National University Hospital (NUHS), Singapore prospective clinical study:
- 33% IOP reduction at 18 months, N = 38 patients
- 61% med reduction (2.1 to 1.3)
- 73% success rate with 1.3 sessions
Tan A, Chockalingam M, Aquino M, Lim Z, See J, Chew P. Micropulse transscleral diode laser cyclophotocoagulation in the treatment of refractory glaucoma. Clin Experiment Ophthalmol. 2010;38(3):266-72
MicroPulse technology finely controls thermal elevation by “chopping” a continuous-wave (CW) laser beam into a train of repetitive short pulses allowing tissue to cool between pulses and reduce thermal buildup preventing visible tissue damage.